🌿 Environment May 7, 2026 · Kristin Jensen

Entrada shares dive as Duchenne results disappoint

BioPharma Dive
BioPharma industry news
View Channel →
Entrada shares dive as Duchenne results disappoint
Source ↗ 👁 1 💬 0
While the company claimed a victory, analysts said data from a Phase 1/2 study fell short of expectations. Entrada shares subsequently tumbled more than 50%.

Comments (0)

Sign in to join the discussion

More Like This

Northern Ireland launches public consultation on new geothermal regulatory framework
ThinkGeoEnergy – Geothermal News & Insights · 6d ago
Tender – Slim hole drilling for Ngozi geothermal project, Tanzania
ThinkGeoEnergy – Geothermal News & Insights · 6d ago
California hazardous waste rules criticized as years late and ‘polluter-friendly’
EHN · May 17, 2026
Minnesota sues 3M, says ‘forever chemicals’ from Cottage Grove continue to pollute water
EHN · May 17, 2026
The American epoch of oil is collapsing. What comes next could be ugly | Jonathan Watts
Environment | The Guardian · May 17, 2026
Readers reply: Which organisms are most beneficial to humans without us realising?
Environment | The Guardian · May 17, 2026